Kathleen Daneberg, CEO of Response Genetics, Inc., presides over the closing bell.

Friday June 8, 2007
from Nasdaq MarketSite
in New York's Times Square

Response Genetics, Inc.
[RGDX]

Response Genetics, Inc. ("RGI") (Nasdaq:RGDX) is engaged in the research and development of pharmacogenomic cancer diagnostic tests based on its proprietary and patented technologies which enable extraction and analysis of genetic information from genes derived from tumor samples stored as formalin-fixed and paraffin embedded specimens.

RGI currently generates revenue primarily from the sales of its proprietary analytical pharmacogenomic testing services of clinical trial specimens to the pharmaceutical industry. The company was founded in 1999 and is located in Los Angeles, California. For more information, please visit www.responsegenetics.com.

Reprints

Click for larger pictures of the NASDAQ MarketSite. Additional Photographs for 06/08/2007 Download Hi-Res Quality Photo of this NASDAQ Market Open - Pictured: Kathleen Daneberg, CEO of Response Genetics, Inc., presides over the closing bell. Organizations interested in obtaining NASDAQ-listed company bell ringing ceremony photographs for press purposes, must first receive approval from the listed company before requesting photographs from NASDAQ. Please provide the company contact information from whom you received approval to Jolene Libretto at Jolene.Libretto@nasdaq.com. Kindly credit © 2007, The Nasdaq Stock Market, Inc. Reprinted with permission. © Copyright 2007, The NASDAQ Stock Market, Inc. Reprinted with the permission of The Nasdaq Stock Market, Inc.